Please Wait
Applying Filters...
menu
    • menu
    As a CDMO, Mikart offers integrated CDMO services for Solid Dose & Non-sterile Liquid formulations.

    Virtual Booth

    Contact Supplier

    LEBSA- Your strategic API source for niche molecules.

    Virtual Booth

    Contact Supplier

    Inke S.A: APIs manufacturing plant.

    Virtual Booth

    Contact Supplier

    Polpharma is a Polish CDMO of APIs and a significant European API producer, delivering products to companies worldwide.

    Virtual Booth

    Contact Supplier

    EUROAPI, the leading small molecules API player, provides both API sales & CDMO services.

    Virtual Booth

    Contact Supplier

    jdmfs-not-supported-m-2025-08-11

    Virtual Booth

    An Enquiry

    Menu

    Resveratrol

    ACTIVE PHARMA INGREDIENTS

    DEVELOPMENTS

    INTERMEDIATES

    FINISHED DOSAGE FORMULATIONS

    DIGITAL CONTENT

    MARKET PLACE

    REF. STANDARDS & IMPURITIES

    PharmaCompass
    $ API Ref.Price (USD/KG) : 243Xls

    Filters

    clear-filterReset all filters
    Left Arrow
    Right Arrow

    Digital Content read-more

    Create Content with PharmaCompass, ask us

    NEWS #PharmaBuzz

    read-more
    read-more
    Jupiter Neurosciences Complies with Nasdaq Minimum Bid Price Rule
    Jupiter Neurosciences Complies with Nasdaq Minimum Bid Price Rule

    10 Jul 2025

    // GLOBENEWSWIRE

    https://www.globenewswire.com/news-release/2025/07/10/3113671/0/en/Jupiter-Neurosciences-Regains-Compliance-with-Nasdaq-Minimum-Bid-Price-Requirement.html

    GLOBENEWSWIRE
    10 Jul 2025
    Share Share
    Stopping dementia at the nose with combination of rifampicin and resveratrol
    Stopping dementia at the nose with combination of rifampicin and resveratrol

    30 Dec 2021

    // SCIENCEDAILY

    https://www.sciencedaily.com/releases/2021/12/211229084259.htm

    SCIENCEDAILY
    30 Dec 2021
    Share Share
    Jupiter Orphan Therapeutics Announces U.S. Patent Its Resveratrol Formulation
    Jupiter Orphan Therapeutics Announces U.S. Patent Its Resveratrol Formulation

    01 Oct 2020

    // PRNEWSWIRE

    https://www.prnewswire.com/news-releases/jupiter-orphan-therapeutics-announces-us-patent-for-its-resveratrol-formulation-301143877.html

    PRNEWSWIRE
    01 Oct 2020
    Share Share
    Jupiter Orphan Announces Federal Grant to ADVANCE JOTROL for Alzheimer's
    Jupiter Orphan Announces Federal Grant to ADVANCE JOTROL for Alzheimer's

    22 Sep 2020

    // PRNEWSWIRE

    https://www.prnewswire.com/news-releases/jupiter-orphan-announces-federal-grant-to-advance-jotrol-to-phase-i-clinical-trial-for-alzheimers-301135649.html#:~:text=JUPITER%2C%20Fla.%2C%20Sept.,study%20of%20JOTROL%E2%84%A2%2C%20for

    PRNEWSWIRE
    22 Sep 2020
    Share Share
    Synergy Issues Voluntary Recall of the Products Due to Lack of Quality Assurance
    Synergy Issues Voluntary Recall of the Products Due to Lack of Quality Assurance

    17 Feb 2017

    // FDA

    https://www.fda.gov/Safety/Recalls/ucm542405.htm

    FDA
    17 Feb 2017
    Share Share
    New Evidence Resveratrol May Slow Alzheimer’s
    New Evidence Resveratrol May Slow Alzheimer’s

    14 Sep 2015

    // TIME

    http://time.com/4032194/red-wine-alzheimers/

    TIME
    14 Sep 2015
    Share Share